RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
MarketWatch: Biotechnology
Dec 2008 - 35 pages - $200
The Dermatology Market Outlook to 2016
Jul 2011 - 96 pages - $3,835
Medicis Pharmaceutical Corporation: Premium Company Profile
Dec 2007 - 49 pages - $495
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
The World Dermatological Market Outlook 2010-2024
Nov 2009 - 142 pages - $2,350
China Dasheng Biotechnology Co (CDBT) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Phage Biotechnology Corporation – Product Pipeline Review – Q4 2010
Dec 2010 - 25 pages - $500
Business Trends: Pharmaceutical Technology - Understanding your Pharmaceutical Customer (Customer Focus)
Dec 2007 - 65 pages - $3,395
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Dermatological del
Hyperkeratosis del
Development phase
Preregistration del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us